Menu
You need to have answered the questions for this stock to see this page
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1,030.5

€1,030.5

1.270%
13.0
1.270%
€1,087.6
 
19.09.24 / Tradegate WKN: 881535 / Symbol: REGN / Name: Regeneron / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Regeneron Pharmaceuticals Inc. Stock

There is an upward development for Regeneron Pharmaceuticals Inc. compared to yesterday, with an increase of €13.00 (1.270%).
With 48 Buy predictions and 1 Sell predictions Regeneron Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 1087 € shows a slightly positive potential of 5.48% compared to the current price of 1030.5 € for Regeneron Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Regeneron Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Pros and Cons of Regeneron Pharmaceuticals Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Regeneron Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Regeneron Pharmaceuticals Inc. 1.270% -0.966% -4.204% 32.923% 28.589% 84.808% 296.789%
Incyte Corp. 1.160% 2.408% 4.079% 5.350% 3.419% -9.444% -17.573%
Exact Sciences 1.860% 7.077% 17.005% -11.499% -9.033% -32.401% -34.770%
Amgen Inc. 0.430% 0.083% 2.795% 21.730% 15.004% 60.267% 69.571%

Comments

Prediction Buy
Perf. (%) 0.68%
Target price 1152.646
Change
Ends at 17.09.25

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,282.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.53%
Target price 1125.750
Change
Ends at 05.09.25

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,250.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Show more

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for REGN provided by MarketBeat
Show more

News

Biotech Breakout: Stocks for Your Watchlist: https://www.marketbeat.com/logos/articles/med_20240911110018_biotech-breakout-stocks-for-your-watchlist.jpg
Biotech Breakout: Stocks for Your Watchlist

After a prolonged consolidation and downtrend following the pandemic-driven surge, the biotechnology sector is readying for a potential breakout and shifting its narrative. Represented by the

Prediction: These 2 Cathie Wood Stocks Could Crush the Market Through 2030: https://g.foolcdn.com/editorial/images/788203/physician-talking-to-patient.jpg
Prediction: These 2 Cathie Wood Stocks Could Crush the Market Through 2030

Is Cathie Wood a genius investor? The CEO of Ark Invest, an investment management firm, rose in prominence in the early days of the pandemic; her firm's actively managed ETFs performed well even as

Is Regeneron Pharmaceuticals Due for a Stock Split?: https://g.foolcdn.com/editorial/images/784798/doctor-meeting-a-salesperson.jpg
Is Regeneron Pharmaceuticals Due for a Stock Split?

Regeneron Pharmaceuticals (NASDAQ: REGN) stock is trading above the $1,000 mark. It's at a high enough threshold that the company could decide to split its stock. That would lower the share price